Naoko Ronquest, PhD
Senior Director, Health Economics and Outcomes Research
RTI Health Solutions
The Institute for Clinical and Economic Review, or ICER, is an independent, non-partisan research organization, specializing in evaluating the value of health technologies in the US. Since its foundation in 2006, ICER has increased its number of evaluations from 2 per year to 12 a year.
ICER’s assessments are serving as important sources for the negotiations between manufacturers and payers. For example, in a recent study, the majority of payers interviewed reported they would use an ICER cost-effectiveness threshold price as a basis for negotiating contracts.
In 2018, we conducted a comprehensive review of recent ICER assessments and uncovered the importance of stakeholders providing solution-oriented guidance in their public comments.
To leverage ICER’s evaluations as opportunities to communicate the value of health technologies, we at RTI Health Solutions recommend a proactive, efficient, and strategic approach in preparing for each evaluation.
A systematic review of ICER evaluations from 2008 to 2018 - recent trends in evaluation process and lessons learned. Ronquest NA, Gould IG, Barnett CL, Mladsi DM. Poster given at the ISPOR 24th Annual International Meeting; May 21, 2019. New Orleans, LA.
What You Need to Know About ICER Evaluations - infographic